Sponsors (77)
Official title: To prohibit the limitation of access to assisted reproductive technology, and all medical care surrounding such technology.
Introduced March 11, 2025 by Laura Gillen · Last progress March 11, 2025
The bill greatly expands and federalizes access to assisted reproductive technology—creating clearer rights, enforcement tools, and potential insurance coverage—while trading off state policy flexibility, raising litigation and administrative burdens, and creating potential cost and provider-access challenges.
People seeking fertility care (women, parents, people with disabilities, patients with chronic conditions) gain a clear federal right to access assisted reproductive technology (ART) and protection against state or local bans, increasing availability of fertility treatments.
Individuals and providers have stronger remedies because the federal government (DOJ) enforcement plus a private right to sue and fee-shifting improve chances of effective relief against unlawful restrictions on ART.
Health insurers are explicitly allowed (and encouraged) to cover ART, which could increase insurance coverage and reduce out-of-pocket expenses for patients seeking fertility services.
State and local governments (and voters) lose policy flexibility because federal preemption limits their ability to set reproductive policy and may override local values or future state legislation.
The law creates a large litigation exposure: broad private rights to sue, fee-shifting, and federal enforcement will likely spur lawsuits by or against clinics, providers, and governments, raising legal costs and operational uncertainty.
Expanded ART access and encouragement of insurance coverage could increase demand and insurer costs, which may raise premiums or public spending and increase costs for some taxpayers and enrollees.
Based on analysis of 6 sections of legislative text.
Creates a federal right to provide, receive, and insure assisted reproductive technology, preempting conflicting state/federal laws and authorizing civil enforcement.
Creates a federal right for patients to obtain, and for health care providers to deliver, assisted reproductive technology (ART) services free from state or local laws that ban or unreasonably restrict those services. The law preempts conflicting state and federal rules (including RFRA where they conflict), authorizes civil enforcement by the Attorney General and private parties, requires HHS to write implementing regulations within one year, and preserves state health-and-safety regulation that is narrowly tailored to advance patient safety.